ZYVERSA THERAPEUTICS, INC. Stock Issued During Period, Shares, Conversion of Convertible Securities
ZYVERSA THERAPEUTICS, INC. (ZVSA) reported Stock Issued During Period, Shares, Conversion of Convertible Securities of 2.94 million shares for the 11-month period ending 2022-12-12, per its 10-K filed 2023-03-31.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities · last filed 2023-03-31
- 2022-12-12: Stock Issued During Period, Shares, Conversion of Convertible Securities 11 month 2.94M shares.
| Period end | Stock Issued During Period, Shares, Conversion of Convertible Securities 11 month |
|---|---|
| 2022-12-12 | 2.94M shares 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |